VAR has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
VAR has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Varian Medical Systems's enterprise value is $15,810 Mil. Varian Medical Systems's Revenue for the trailing twelve months (TTM) ended in Dec. 2020 was $3,118 Mil. Therefore, Varian Medical Systems's EV-to-Revenue for today is 5.07.
The historical rank and industry rank for Varian Medical Systems's EV-to-Revenue or its related term are showing as below:
During the past 13 years, the highest EV-to-Revenue of Varian Medical Systems was 5.09. The lowest was 2.64. And the median was 3.81.
The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.
EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.
As of today (2024-04-26), Varian Medical Systems's stock price is $177.07. Varian Medical Systems's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2020 was $34.02. Therefore, Varian Medical Systems's PS Ratio for today is 5.21.
The historical data trend for Varian Medical Systems's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Varian Medical Systems Annual Data | |||||||||||||||||||||
Trend | Sep11 | Sep12 | Sep13 | Sep14 | Sep15 | Sep16 | Sep17 | Sep18 | Sep19 | Sep20 | |||||||||||
EV-to-Revenue | Get a 7-Day Free Trial | 3.09 | 3.35 | 3.34 | 3.25 | 4.87 |
Varian Medical Systems Quarterly Data | ||||||||||||||||||||
Mar16 | Jun16 | Sep16 | Dec16 | Mar17 | Jun17 | Sep17 | Dec17 | Mar18 | Jun18 | Sep18 | Dec18 | Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | |
EV-to-Revenue | Get a 7-Day Free Trial | 3.87 | 3.00 | 3.40 | 4.87 | 5.00 |
For the Medical Instruments & Supplies subindustry, Varian Medical Systems's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Varian Medical Systems's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Varian Medical Systems's EV-to-Revenue falls into.
EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.
Varian Medical Systems's EV-to-Revenue for today is calculated as:
EV-to-Revenue | = | Enterprise Value (Today) | / | Revenue (TTM) |
= | 15809.799 | / | 3118.1 | |
= | 5.07 |
Varian Medical Systems's current Enterprise Value is $15,810 Mil.
Varian Medical Systems's Revenue for the trailing twelve months (TTM) ended in Dec. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $3,118 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Varian Medical Systems (NYSE:VAR) EV-to-Revenue Explanation
The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.
Varian Medical Systems's PS Ratiofor today is calculated as:
PS Ratio | = | Share Price (Today) | / | Revenue per Share (TTM) |
= | 177.07 | / | 34.018 | |
= | 5.21 |
Varian Medical Systems's share price for today is $177.07.
Varian Medical Systems's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $34.02.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Varian Medical Systems's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Jesse Michael Bruff | officer: SVP Finance, CFO | 3100 HANSEN WAY, PALO ALTO CA 94304 |
Magnus Momsen | officer: SVP, CAO, Corporate Controller | VARIAN MEDICAL SYSTEMS INC. 3100 HANSEN WAY MAIL STOP E327 PALO ALTO CA 94304 |
Dow R Wilson | director, officer: President and CEO | VARIAN MEDICAL SYSTEMS INC, 3100 HANSEN WAY MAIL STOP E327, PALO ALTO CA 94304 |
Kolleen T Kennedy | officer: Pres. Proton Solutions, CGO | VARIAN MEDICAL SYSTEMS INC, 3100 HANSEN WAY MAIL STOP E327, PALO ALTO CA 94304 |
Christopher A. Toth | officer: SVP and Pres. Oncology Systems | 1252 COOLIDGE AVE., SAN JOSE CA 95125 |
Michael Damon Hutchinson | officer: SVP,Chief Legal Officer, Secy | 2825 AIRVIEW BLVD, KALAMAZOO MI 49002 |
Jean Luc Butel | director | ONE BAXTER PARKWAY, DEERFIELD IL 60015 |
John W Kuo | officer: SVP, Gen Counsel and Secretary | VARIAN MEDICAL SYSTEMS INC, 3100 HANSEN WAY MAIL STOP E327, PALO ALTO CA 94304 |
Judy Bruner | director | C/O SANDISK CORPORATION, 601 MCCARTHY BLVD., MILPITAS CA 95035 |
Beau Michelle Le | director | 800 N. MICHIGAN AVENUE #3703 CHICAGO IL 60611 |
Anat Ashkenazi | director | LILLY CORPORATE CENTER, INDIANAPOLIS IN 46285 |
Jeffrey R. Balser | director | 3657 RICHLAND AVE., NASHVILLE TN 37205 |
Regina E Dugan | director | VARIAN MEDICAL SYSTEMS INC, 3100 HANSEN WAY MAIL STOP E327, PALO ALTO CA 94304 |
David J Illingworth | director | 3100 HANSEN WAY PALO ALTO CA 94304 |
R Andrew Eckert | director | THREE RAVINIA DRIVE, ATLANTA GA 30346 |
From GuruFocus
By PRNewswire PRNewswire • 10-20-2020
By PRNewswire PRNewswire • 11-10-2020
By PRNewswire PRNewswire • 10-12-2020
By PRNewswire PRNewswire • 09-15-2020
By GuruFocus Research GuruFocus Editor • 05-05-2021
By GuruFocus Research GuruFocus Editor • 02-16-2021
By Marketwired Marketwired • 09-25-2020
By PRNewswire PRNewswire • 03-02-2021
By PRNewswire PRNewswire • 09-16-2020
By GuruFocus Research GuruFocus Editor • 03-04-2021
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.